Cagri Akpinar

Dr. Cagri Akpinar

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Endourology
Verified
Journal Article
Closed access
BMBraulio Omar Manzo
Braulio Omar Manzo
PAPompeyo Stalin Alarcon
Pompeyo Stalin Alarcon
EHEdgard Efren Lozada Hernandez
Edgard Efren Lozada Hernandez
JOJorge Ojeda
Jorge Ojeda
CMChristian Morales
Christian Morales
EEEsteban Emiliani
Esteban Emiliani
Objective: The aim of the study is to propose a visual classification for encrusted stents (ESs) to help choose the appropriate endourologic treatment. Materials and Methods: A multicenter, retrospective, and descriptive study was performed. A total of 140 patients with encrusted Double-J stents were enrolled from 5 different institutions. The novel visual grading for ureteral encrusted stent (V-GUES) classification system ranges from A to D, increasing with severity of encrustation. Results: ESs could be removed with a single intervention in 112 patients (86.8%). Type A and B ESs could be removed in all patients (100% success). Type D stents had minor retrieval and stone-free rates ( p = 0.006 and p < 0.0001, respectively). Flexible ureteroscopy had a low success rate (77.7%) for type C stents (odds ratio [OR]: 0.21). Combined access had a 100% success rate for retrieval of type C ESs and a 92.9% success rate for type D ESs (OR: 9.18). Type D stents were associated with patients requiring more than one session to retrieve the stent (OR: 0.11) and stones (OR: 0.21). Conclusions: The V-GUES system is associated with treatment success rates of ES retrieval and stone-free status. It is also associated with the complication rate and the number of sessions needed for patients to be stent and stone free. The V-GUES classification could help counsel patients about the best treatment options and their outcomes. Further prospective studies will be needed to provide external validation.

1 January 2021 in Urology Research and Practice
Verified
Journal Article
Closed access
EÖEriz Özden
Eriz Özden
CACagri Akpinar
Cagri Akpinar
AIArif İbIş
Arif İbIş
EKEralp Kubilay
Eralp Kubilay
AEAyşe Erden
Ayşe Erden
ÖYÖnder Yaman
Önder Yaman
Objective: This study aimed to evaluate the effect of prostate volume and lesion size on the clinically significant prostate cancer (csPCa) detection rates of transrectal ultrasonography (TRUS)-guided prostate biopsies, performed by a cognitive targeting method for sampling peripheral zone lesions. Material and methods: We retrospectively enrolled 219 consecutive patients, who underwent multiparametric magnetic resonance imaging with a 3-T scanner and had peripheral zone lesions suspected for prostate cancer. All of these patients underwent combined cognitive targeted biopsy of suspicious lesions and TRUS-guided systematic biopsy. The detection rates of csPCa according to different lesion diameters (<5 mm, 5–9.9 mm, and ≥10 mm) and prostate volumes (<30 mL, 30–49.9 mL, 50–79.9 mL, and ≥80 mL) were calculated per lesion basis. In addition, subgroup analysis of csPCa detection rates was performed according to Prostate Imaging Reporting and Data System scores of lesions. Results: The csPCa detection rates according to lesion diameters <5 mm, 5–9.9 mm, and ≥10 mm were 4%, 9.8%, and 33.1%, respectively, and were significantly lower for lesions <10 mm (p<0.001). The csPCa detection rates were 61.5%, 24.1%, 16.2%, and 6.9%, respectively, for prostate volumes <30 mL, 30–49.9 mL, 50–79.9 mL, and ≥80 mL, and were significantly higher for prostate volumes <30 mL (p<0.001). Conclusions: Clinicians should be very careful when they prefer cognitive targeted prostatic biopsy in patients with periferal zone lesions less than 10 mm and with prostate volumes greater than 30 mL, because of significantly low csPCa detection rates. Cite this article as: Özden E, Akpınar Ç, İbiş A, Kubilay E, Erden A, Yaman Ö. Effect of lesion diameter and prostate volume on prostate cancer detection rate of magnetic resonance imaging: Transrectal-ultrasonography-guided fusion biopsies using cognitive targeting. Turk J Urol 2021; 47(1): 22-9.

1 June 2019 in Urology
Verified
Journal Article
Closed access
CACagri Akpinar
Cagri Akpinar
ESEvren Suer
Evren Suer
KTKadir Turkolmez
Kadir Turkolmez
YBYasar Beduk
Yasar Beduk


15 February 2021 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
ASAdem Sanci
Adem Sanci
CACagri Akpinar
Cagri Akpinar
MGMehmet Ilker Gokce
Mehmet Ilker Gokce
ESEvren Süer
Evren Süer
OGOmer Gülpinar
Omer Gülpinar

1 November 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
ESEvren Suer
Evren Suer
CACagri Akpinar
Cagri Akpinar
VIVolkan Izol
Volkan Izol
YBYildirim Bayazit
Yildirim Bayazit
SSSinan Sozen
Sinan Sozen
SBSumer Baltaci
Sumer Baltaci
Objectives To investigate the predictors of acute kidney injury (AKI) after partial nephrectomy and the impact of AKI stage on long-term kidney function. Methods Data of 1055 patients who underwent partial nephrectomy between January 2008 and January 2018 at seven separate tertiary centres were analysed. AKI was defined according to AKI Network criteria. The association between pre-operative and perioperative factors and AKI was evaluated using logistic regression analysis. Recovery of at least 90% of baseline glomerular filtration rate 1 year after partial nephrectomy, change of 1 year glomerular filtration rate compared with baseline glomerular filtration rate and stage >= 3 chronic kidney disease (CKD) progression were assessed according to the stage of AKI. Results AKI was recorded in 281 (26.7%) of 1055 patients after partial nephrectomy, and of these patients, 197 (70.1%) had stage 1, 77 (27.4%) had stage 2 and 7 (2.5%) had stage 3. Higher tumour complexity and baseline glomerular filtration rate were independent predictors for AKI. The proportion of recovering 90% of baseline glomerular filtration rate at 1 year for any patient who had stage <= 1 vs stage 2-3 of AKI was 78.2% (95% CI: 73.2%-83.7%) and 23.8% (95% CI: 14.7%-38.7%), respectively (P < .001). The risk of stage >= 3 CKD progression for any patient who had stage <= 1 vs stage 2-3 of AKI was 6.2% (95% CI: 4.1%-9.2%) and 63.1% (95% CI: 52.5%-75.6%), respectively (P < .001). Conclusions AKI adversely affects renal function in the long-term after partial nephrectomy and stage 2-3 significantly increases the risk of CKD in the long term.